Sponsor:University of NebraskaBrief Summary: Parkinson's disease (PD) is a neurodegenerative disorder that leads to both motor and non-motor symptoms. Therapies…
Sponsor:CND Life SciencesBrief Summary: The Synuclein-One Study will be evaluating α-synuclein in patients with Parkinson's disease, Multiple System Atrophy, Dementia…
Sponsor:Stoparkinson Healthcare Systems LLCBrief Summary: A Multicenter, Randomized, Blinded, Electronic Device in Subjects with Parkison Disease. Criteria Inclusion Criteria: 1.…
Sponsor:University of California, San DiegoBrief Summary: This project aims to develop a minimally invasive microneedle sensor to monitor levodopa levels…
Sponsor:University of California, San FranciscoBrief Summary: This is a single-center phase I clinical study aiming to improve gait functions in…
Sponsor:AbbVieBrief Summary: Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how…
Sponsor:UCB Biopharma SRLBrief Summary: The purpose of the study is to assess the safety and tolerability of UCB0599 and to…
Sponsor:Hoffmann-La RocheBrief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous…
Sponsor:Neurocrine BiosciencesBrief Summary: This is an observational study to describe the treatment patterns and clinical outcomes observed with use of…
Sponsor:Cerevance Beta, Inc.Brief Summary: This is a phase 2 study, randomized, double-blind, placebo-controlled, multicenter study of oral CVN424 at two…
